Mobile Health App With Social Media to Support Self-Management for Patients With Chronic Kidney Disease: Prospective Randomized Controlled Study.
Wen-Yi Li, Fu-Chun Chiu, Jyun-Kai Zeng...
https://pubmed.ncbi.nlm.nih.gov/33320101/Actively Recruiting
Led by Northwell Health · Updated on 2026-10-20
160
Participants Needed
2
Research Sites
43 weeks
Total Duration
This trial studies adults who have experienced acute kidney injury AKI during hospitalization and aims to improve how information and follow-up care are provided after hospital discharge. Researchers want to see if an AKI discharge summary template and a chat-based educational messaging program can help enhance communication, patient understanding, and follow-up care after AKI. Participants will be randomly assigned to one of four groups usual care, usual care plus the AKI discharge summary template, usual care plus access to the chat-based educational messaging program, or usual care with both the discharge summary template and chat-based messaging. The discharge summary template helps communicate AKI-related information to outpatient care providers, while the chat program delivers educational messages through a secure online chat interface after discharge. Participants complete questionnaires at the study start and about four weeks after discharge, along with a brief phone call around three months post-discharge. Researchers will review medical records to track follow-up care, kidney function monitoring, emergency visits, and readmissions. The study evaluates feasibility, participant retention, delivery of interventions, patient knowledge, experience, and adherence to recommended follow-up activities over approximately three months.
CONDITIONS
COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI)
J
Jia Hwei Ng, MD, MSCE
F
Farwa Batool, MPH
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Northwell Health
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | AKI Discharge Summary Template | Usual Care (Standard Practice) | Chat-Based Educational Messaging Program | Discharge Summary Template + Chat-Based Messaging |
|---|---|---|---|---|
| What it is | A structured discharge summary template that adds AKI-specific information and recommended follow-up guidance to the standard hospital discharge process. | Usual post-hospitalization care and communication provided during hospital discharge and aftercare for patients with acute kidney injury. | AKI-related educational messages delivered post-discharge through a secure, web-based chat interface. | Both the structured discharge summary template and the chat-based educational messaging are provided, combining the two interventions for patients. |
| Role in the trial | Evaluates whether adding AKI-specific discharge documentation improves care transitions. | Serves as the comparator arm reflecting standard hospital and post-discharge care processes. | Evaluates if post-discharge digital education supports patient understanding and follow-up. | Assesses the combined effect of structured discharge documentation and digital education after AKI. |
| Primary use | Provides targeted AKI information and planning at discharge to enhance care coordination. | General hospital discharge and outpatient follow-up as per routine practice. | Delivers AKI education after discharge to reinforce knowledge and recommended actions for kidney care. | Combines improved discharge summary and post-discharge education for comprehensive care support after AKI. |
| How it is performed or delivered | A structured template is included with the discharge summary and sent to outpatient providers to detail AKI event and follow-up needs. | Typical hospital discharge process with standard discharge summary and routine communication to outpatient providers. | Educational messages are delivered to patient via secure web platform after leaving the hospital. | Patients receive both the structured discharge summary and web-based educational messages after discharge. |
| Evidence status | The benefit of adding an AKI-specific discharge template is being studied in this trial. Similar structured discharge efforts in other settings have improved provider communication but published evidence specific to AKI is limited. | Usual care for AKI discharge is established practice but often results in incomplete information transfer and suboptimal follow-up. | Digital education interventions have improved patient knowledge and engagement in chronic kidney disease and other chronic illnesses, but effects after AKI hospitalization are not well established. | The effect of combining structured discharge and digital education for AKI is not yet established; the trial will generate first-hand evidence. |
| Important limitations | The effectiveness of a discharge summary template may depend on provider engagement and the ability of outpatient teams to act on the information. Formal outcome data in post-AKI populations are limited. | Usual care often leads to incomplete AKI information transfer and missed opportunities for kidney-related follow-up. Gaps may result in suboptimal self-management. | Digital messaging may not reach all patients equally, especially those with limited technology access or digital literacy. Evidence in acute post-hospitalization AKI is currently limited. | The combined effects and potential added burden of receiving both interventions in a vulnerable post-AKI population are not yet known until study completion. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 3 months after hospital discharge
Participants receive usual hospital discharge care and may also receive the AKI discharge summary template, access to the chat-based educational messaging program, or both, depending on their assigned group. They complete questionnaires at the start and about four weeks after discharge, plus a phone call around three months after discharge. Researchers review medical records for follow-up care and health outcomes.
Questionnaires and brief phone call during follow-up
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Have more questions? Get in touch with our team for quick support
Wen-Yi Li, Fu-Chun Chiu, Jyun-Kai Zeng...
https://pubmed.ncbi.nlm.nih.gov/33320101/Michael Heung, Diane E Steffick, Kara Zivin...
https://pubmed.ncbi.nlm.nih.gov/26690912/Samuel A Silver, Ziv Harel, Eric McArthur...
https://pubmed.ncbi.nlm.nih.gov/27751901/Julie A Wright, Kenneth A Wallston, Tom A Elasy...
https://pubmed.ncbi.nlm.nih.gov/21168943/Whitney Chadwick, Hannah Bassett, Sarah Hendrickson...
https://pubmed.ncbi.nlm.nih.gov/31243058/Harvey Newnham, Anna Barker, Edward Ritchie...
https://pubmed.ncbi.nlm.nih.gov/29025093/T Alp Ikizler, Chirag R Parikh, Jonathan Himmelfarb...
https://pubmed.ncbi.nlm.nih.gov/32707221/John D Piette, Dana Striplin, Nicolle Marinec...
https://pubmed.ncbi.nlm.nih.gov/26063161/Eric A J Hoste, Sean M Bagshaw, Rinaldo Bellomo...
https://pubmed.ncbi.nlm.nih.gov/26162677/Samuel A Silver, Glenn M Chertow
https://pubmed.ncbi.nlm.nih.gov/28595193/Northwell Health
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor